Trial Profile
Prospective randomized open study on the comparison of fondaparinux with the low-molecular-weight heparin enoxaparin in patients undergoing femoro-distal venous bypass operation.
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Aug 2011
Price :
$35
*
At a glance
- Drugs Fondaparinux sodium (Primary) ; Enoxaparin sodium
- Indications Embolism and thrombosis; Peripheral arterial occlusive disorders
- Focus Adverse reactions; Therapeutic Use
- 23 Aug 2011 New trial record